Vaniqa Rx Facial Hair Remover May Be Strong OTC Switch Candidate
This article was originally published in The Tan Sheet
Executive Summary
Ongoing studies of Bristol-Myers Squibb's newly approved Vaniqa prescription hair removal drug could broaden the topical cream's target population to include men. FDA approved the product for removal of women's facial hair July 27.